These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29035388)

  • 21. Association between frequent CpG island methylation and HER2 amplification in human breast cancers.
    Terada K; Okochi-Takada E; Akashi-Tanaka S; Miyamoto K; Taniyama K; Tsuda H; Asada K; Kaminishi M; Ushijima T
    Carcinogenesis; 2009 Mar; 30(3):466-71. PubMed ID: 19168584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.
    Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V
    Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
    Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
    Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced gene expression in breast cancer cells in vitro and tumors in vivo.
    Lu H; Zhang Y; Roberts DD; Osborne CK; Templeton NS
    Mol Ther; 2002 Dec; 6(6):783-92. PubMed ID: 12498774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers.
    Mungamuri SK; Murk W; Grumolato L; Bernstein E; Aaronson SA
    Cell Rep; 2013 Oct; 5(2):302-13. PubMed ID: 24120871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.
    Redmond AM; Omarjee S; Chernukhin I; Le Romancer M; Carroll JS
    PLoS One; 2019; 14(11):e0225180. PubMed ID: 31747426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
    Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
    Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hyper-activation of transcriptional enhancers in breast cancer.
    Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
    Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A positive role for PEA3 in HER2-mediated breast tumour progression.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
    Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression.
    Wang H; Yan C; Asangani I; Allgayer H; Boyd DD
    Oncogene; 2007 Mar; 26(14):2058-70. PubMed ID: 17001307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
    Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
    Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
    Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
    Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 100 bp GAGA motif-containing sequence in AGAMOUS second intron is able to suppress the activity of CaMV35S enhancer in vegetative tissues.
    Liu R; Zou X; Wang Y; Long Q; Pei Y
    PLoS One; 2020; 15(3):e0230203. PubMed ID: 32134990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional elements demarcated by histone modifications in breast cancer cells.
    Choe MK; Hong CP; Park J; Seo SH; Roh TY
    Biochem Biophys Res Commun; 2012 Feb; 418(3):475-82. PubMed ID: 22285863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.